home All News open_in_new Full Article

LabPMM® Receives New York State Approval for the NPM1 MRD Assay – Informing Therapy and Accelerating Targeted Trials

SAN DIEGO — Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical […]


today 40 h. ago attach_file Other

attach_file Events
attach_file Economics
attach_file Other
attach_file Sport
attach_file Other
attach_file Politics
attach_file Politics
attach_file Culture
attach_file Other
attach_file Culture
attach_file Society
attach_file Society
attach_file Society
attach_file Other
attach_file Politics
attach_file Economics
attach_file Other
attach_file Politics
attach_file Economics
attach_file Events


ID: 3427616034
Add Watch Country

arrow_drop_down